期刊文献+

巴利昔单抗在心脏移植免疫诱导治疗中的应用 被引量:2

Application of basiliximab for immune induction therapy in heart transplantation
下载PDF
导出
摘要 白细胞介素-2(IL-2)受体拮抗剂-巴利昔单抗应用于心脏移植免疫诱导治疗,可以显著减少心脏移植术后早期急性排斥反应的发生,且未显著增加移植后感染发生率,同时可延迟或减少钙调磷酸酶抑制剂的应用,有利于保护肾功能、促进移植物功能恢复。本文总结了巴利昔单抗的作用机制、药代动力学和临床应用,以及比较巴利昔单抗与抗胸腺细胞球蛋白在心脏移植免疫诱导治疗中的应用,为心脏移植受者免疫抑制剂的合理使用提供参考。 The application of interleukin-2 receptor antagonist basiliximab to immune induction therapy for heart transplantation can significantly reduce the occurrence of early acute rejection after heart transplantation without increasing postoperative infection.At the same time,it can delay or reduce the use of calcineurin inhibitors,which is beneficial to protect renal function and promote the recovery of graft function.In this paper,we summarized the mechanism of action,pharmacokinetics and clinical application of basiliximab,and compared the application of basiliximab and anti-thymocyte globulin in the immune induction therapy of heart transplantation,so as to provide reference for the rational use of immunosuppressants for heart transplantation recipients.
作者 侯杰 Hou Jie(TEDA International Cardiovascular Hospital,Tianjin 300457)
出处 《天津药学》 2020年第3期59-63,共5页 Tianjin Pharmacy
关键词 巴利昔单抗 心脏移植 诱导治疗 急性排斥反应 basiliximab heart transplantation induction therapy acute rejection
  • 相关文献

参考文献15

二级参考文献78

  • 1卢晓云,邹晓平,徐肇敏.肝移植术后胆管狭窄机理的初步探讨[J].中华消化内镜杂志,2006,23(4):317-320. 被引量:1
  • 2韩杰,孟旭,张海波,曾文,许春雷,李菲,孙凌波.原位心脏移植51例临床经验[J].中华胸心血管外科杂志,2006,22(6):390-391. 被引量:9
  • 3Wedemeyer H, Pethig K, Wagner D, et al. Long-term outcome of chronic hepatitis B in heart transplant recipients. Transplantation, 1998,66 : 1347-1353.
  • 4Lau JY, Bain VG, Smith HM, et al. Modulation of hepatitis B viral antigen expression by immunosuppressive drugs in primary hepatocyte culture. Transplantation, 1992,53:894-898.
  • 5Ying C, De Clercq E, Neyts J. Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus. Antiviral Res, 2000,48 : 117-124.
  • 6Viberti G. Diabetes mellitus:a major challenge in transplantation. Transplant Proc,2001,33 Suppl 5A:S3-6.
  • 7Ouseph R, Brier ME, Jacobs AA, et al. Continuous venovenous hemofiltration and hemodialysis after orthotopic heart transplanation. Am J Kidney Dis, 1998,32:290-294.
  • 8Coopersmith CM, Brennan DC, Miller B, et al. Renal transplantation following previous heart, liver, and lung transplantation:an 8-year single-center experience. Surgery, 2001, 130:457-462.
  • 9Carrier M, White M, Perrault LP, et al. A 10-year experience with intravenous thymoglobuline in induction of immunosup- pression following heart transplantation. J Heart Lung Trans- plant, 1999, 18(12):1218-1223.
  • 10Beniaminovitz A, Itescu S, Lietz K, et al. Prevention of rejec- tion in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. N Engl J Med, 2000, 342(9) :613-619.

共引文献260

同被引文献20

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部